Breast cancer is a heterogeneous disease with different molecular subtypes that are characterized, at a minimum, by the expression of the estrogen receptor (ER), progesterone receptor (PR), and Human epidermal growth factor receptor 2 (HER2)/neu1. This evidence concerns the gene PGR and breast carcinoma.